Importantly, these findings suggest method of presentation is a key factor in prostate cancer outcome studies and is an important covariate when comparing outcomes between patient groups with differing proportions of men who are symptomatic and PSA-detected. The gene discussed is KLK3; the disease is prostate carcinoma.